Clinical trial

Pharmacogenetics-guided Isoniazid Dosing in TB-HIV

NCT05124678

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-12-07

PhasePHASE2

Study timeline

Study start (actual)2021-12-07Date precision: day

Registry last updated2022-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberculosisunresolved

Interventions

Isoniazid TabletsDRUG

Sponsors & collaborators

Makerere Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05124678 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.